|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.097 AUD | +5.43% |
|
+3.19% | -11.82% |
| Apr. 22 | Australian Shares Rebound Amid Easing Middle East Tensions, Ahead of Local Inflation Data | MT |
| Apr. 22 | PYC Therapeutics Confirms Safety, Tolerability of Kidney Medication in Animal Study | MT |
PYC Therapeutics Limited reported earnings results for the full year ended June 30, 2023. For the full year, the company reported revenue was AUD 15.91 million compared to AUD 16.07 million a year ago. Net loss was AUD 22.79 million compared to AUD 13.86 million a year ago.
Basic loss per share from continuing operations was AUD 0.0071 compared to AUD 0.0044 a year ago. Diluted loss per share from continuing operations was AUD 0.0071 compared to AUD 0.0044 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -11.82% | 270M | |
| +1.77% | 42.86B | |
| +45.43% | 41.36B | |
| +12.24% | 42.74B | |
| -8.83% | 27.68B | |
| +7.44% | 25.15B | |
| -23.01% | 18.63B | |
| +30.56% | 12.37B | |
| -1.82% | 11.92B | |
| +8.35% | 11.21B |
PYC THERAPEUTICS LIMITED 
